Combines generative models with proprietary biological data and laboratory validation to design new protein-based medicines, including antibodies against targets that conventional discovery methods struggle to address.
Former members 1
Related organizations
Based on public sources. If accuracy is important, verify details using the links or references.
For corrections, updates, or requests to remove information, contact us.
Reviewed August 10, 2026 · Checked for accuracy and new information.